The LAMA1 gene helps make laminin, a support protein that helps tissues hold their shape as the body develops. This gene plays an important role in forming parts of the brain and eyes. If the LAMA1 gene does not work properly, it can lead to a condition called Poretti-Boltshauser syndrome, which may cause delayed development, poor balance and coordination, unusual eye movements, and vision problems. LAMA1 is mainly known in medical genetics rather than in popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the parts of cells that do the work. Others mainly control when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
LAMA1Gene function
What if the gene works
The LAMA1 gene helps make laminin, a protein that supports the thin layer holding cells in place. It is especially important during early development of the brain, eyes, and other tissues.
Risk
What if the gene does not work
Variants in the LAMA1 gene most often affect brain and eye development, leading to balance problems, delayed development, and vision changes. Milder and more severe variants can influence when symptoms appear and how strongly movement, learning, and sight are affected.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the LAMA1 gene, no LAMA1-specific treatment or management approach is currently established. LAMA1 is being studied in early-stage research as a biomarker in some cancers and in tissue development, but this has not yet changed routine drug choices.
Conditions associated with LAMA1
Gene function
What if the gene works
Your cells use the LAMA1 gene to make part of laminin, a protein that helps form the thin support layer under many tissues. This layer gives cells a surface to attach to and helps tissues keep their shape. It also passes signals that guide how cells grow, move, and organize. This steady support is part of what the LAMA1 gene does in the body every day.
The LAMA1 gene helps build the basement membrane, a thin sheet that supports and separates nearby tissues. This gives cells a stable surface and helps organs keep their structure.
Laminin made with LAMA1 helps cells attach to their surroundings in a controlled way. That attachment supports everyday tasks such as staying in place, spreading out, and forming neat layers.
This protein also helps cells sense the surface around them. Those signals can guide cell survival, growth, and shape as tissues renew themselves.
During early development, laminin made with LAMA1 helps direct where cells move and how they arrange into tissues. This is especially important while delicate body structures are taking shape.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal differences between people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LAMA1 gene can weaken how the laminin alpha-1 protein is made, folded, or linked into the cell supporting scaffold around developing tissues. Some changes slightly alter the protein, while more severe variants can shorten it or stop production almost completely. These LAMA1 gene variant effects can range from partial loss of function to near absence of function, which may influence how early and how strongly LAMA1-related brain and eye features appear.
How variants are linked to conditions
Pathogenic variants in the LAMA1 gene cause Poretti-Boltshauser syndrome, so LAMA1 gene variants are most clearly linked to this rare inherited condition. It is associated with changes in the cerebellum, which can affect balance and coordination, along with developmental delay and eye problems such as severe nearsightedness or retinal changes. In this setting, finding disease-causing variants in both copies of the LAMA1 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For LAMA1-related conditions, risk is mainly linked to inheriting disease-causing changes in both copies of the LAMA1 gene, usually one from each parent. There is not yet broadly confirmed evidence that lifestyle, diet, or other outside factors meaningfully increase or reduce this genetic risk, so personal risk questions are best discussed with a doctor or genetic counselor.
Inheritance of LAMA1 variants
For families asking about the LAMA1 gene inheritance pattern, the well-established pattern is autosomal recessive. This means a person usually inherits one LAMA1 variant from each parent, and parents who each carry one variant typically do not have symptoms themselves. When both parents are carriers, each pregnancy has a 25% chance of a child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because the LAMA1 gene is on an autosome, this pattern is the same for sons and daughters.
What does my LAMA1 result mean for my family?
For families with a disease-causing change in the LAMA1 gene, close relatives may also be carriers, even if they do not have symptoms. Brothers and sisters could be affected or could be carriers, and other relatives on both sides of the family may also carry the same gene change. This often means family members may want to learn whether the change is present in them too.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the LAMA1 gene, clinicians use genetic testing on blood, saliva, or sometimes a cheek swab. Genetic testing for LAMA1 variants reads the DNA code and checks for changes linked to symptoms or family history. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the LAMA1 gene may be considered when a child has signs that fit an inherited condition linked to this gene, such as developmental delay, poor balance or coordination, and certain brain or eye findings. It can also be helpful when there is a family history of the same condition or a known LAMA1 variant in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the kind of variant involved. How the body functions over time is also shaped by many other influences, including lifestyle, environment, age, and medical history. For some conditions, especially those linked to many genes, genetic information provides context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same medication can work well for one person but not as well for another, or why side effects can differ from person to person. These differences are common and are one part of the reason treatment response varies.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the LAMA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. General concerns about your health, new symptoms, side effects, or how medicines may affect you are best discussed with your doctor or pharmacist.
History
LAMA1 entered medical research through studies of laminins, a family of proteins identified as key parts of the body’s supporting tissues. In recent decades, awareness of this gene’s role has grown as researchers connected it to inherited patterns affecting brain and eye development. Early work placed the LAMA1 gene within the broader laminin family, helping scientists map how these related genes were organized and named. From these first observations, research expanded steadily. A major step came when damaging variants in the LAMA1 gene were linked to a recognizable condition now known as Poretti-Boltshauser syndrome. That finding turned LAMA1 from a laboratory gene into one with clear clinical importance for diagnosis and family counseling.